Kobayashi Pharmaceutical Co., Ltd.

48
Sell
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3301100008
JPY
5,201.00
-89 (-1.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Kobayashi Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
13,914.00
27,559.00
27,950.00
27,636.00
26,635.00
26,804.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-2,612.00
-6,579.00
6,403.00
-1,950.00
220.00
-3,894.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
11,246.00
18,360.00
31,914.00
22,419.00
23,986.00
20,089.00
Cash Flow from Investing Activities
-18,415.00
-19,576.00
-14,312.00
7,991.00
-12,656.00
-5,072.00
Cash Flow from Financing Activities
-7,768.00
-19,463.00
-20,759.00
-10,377.00
-6,019.00
-14,581.00
Net Cash Inflow / Outflow
-13,717.00
-19,789.00
-2,484.00
20,830.00
4,886.00
357.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
1,220.00
890.00
673.00
797.00
-425.00
-79.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Kobayashi Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
13914
217.66936695849
13,697.00
6292.26%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-2612
-9.20176624168544
-2,603.00
-28285.85%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
11246
302.337422978618
10,944.00
3619.69%
Cash Flow from Investing Activities
-18415
-200.195603959043
-18,215.00
-9098.50%
Cash Flow from Financing Activities
-7768
-80.262719655824
-7,688.00
-9578.22%
Net Cash Inflow / Outflow
-13717
33.6488003705578
-13,750.00
-40865.20%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
1220
11.769701006807
1,209.00
10265.60%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is -38.75% vs -42.47% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
11,246.00
18,360.00
-38.75%